The 20 Best Diffuse Large B-Cell Lymphoma (DLBCL) Doctors Near Me in Houston, TX
Find the Top Diffuse Large B-Cell Lymphoma (DLBCL) Experts and Specialists
MediFind found 102 doctor with experience in Diffuse Large B-Cell Lymphoma (DLBCL) near Houston, TX. Of these, 72 are Experienced, 16 are Advanced, 10 are Distinguished and 4 are Elite.
UT MD Anderson Cancer Center
Luis Fayad is an Oncologist in Houston, Texas. Dr. Fayad is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Tissue Biopsy.
UT MD Anderson Cancer Center
Sattva Neelapu is an Oncologist in Houston, Texas. Dr. Neelapu is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Transplant.
Office
Nathan Fowler is a Hematologist in Houston, Texas. Dr. Fowler is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration.
Office
Fredrick Hagemeister is an Oncologist in Houston, Texas. Dr. Hagemeister is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration.
Office
Chitra Hosing is a Hematologist in Houston, Texas. Dr. Hosing is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Baylor College Of Medicine - Hem/Onc
Martha Mims, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Martha Mims specializes in Medical Oncology and works at BCM Medicine - Hem/Onc. To make an appointment, please call (713) 798-3750. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Mims is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Hypereosinophilic Syndrome, Essential Thrombocythemia, Non-Hodgkin Lymphoma, and Clear Cell Sarcoma.
MD Anderson
Dai Chihara is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Chihara is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Peripheral T-Cell Lymphoma, T-Cell Lymphoma, and Bone Marrow Aspiration.
UT MD Anderson Cancer Center
Maria Rodriguez is an Oncologist in Houston, Texas. Dr. Rodriguez is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Follicular Lymphoma, Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration.
UT MD Anderson Cancer Center
Luhua Wang is an Oncologist in Houston, Texas. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Multiple Myeloma, Bone Marrow Aspiration, and Colonoscopy.
Office
Sairah Ahmed is a Hematologist in Houston, Texas. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.
Outpatient Center
Siddhartha Ganguly is a Hematologist in Houston, Texas. Dr. Ganguly is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ganguly is currently accepting new patients.
Office
Issa Khouri is a Hematologist in Houston, Texas. Dr. Khouri is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), T-Cell Lymphoma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Outpatient Center
Carrie Yuen is a Hematologist in Houston, Texas. Dr. Yuen is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Yuen is currently accepting new patients.
Office
Yago Nieto is a Hematologist in Houston, Texas. Dr. Nieto is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Center For Cell And Gene Therapy
Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease. Dr. Kamble is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.
MD Anderson
Bouthaina Dabaja is a Radiation Oncologist and an Oncologist in Houston, Texas. Dr. Dabaja is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Mycosis Fungoides.
UT MD Anderson Cancer Center
Chi Ok is a Laboratory Medicine provider in Houston, Texas. Dr. Ok is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), and Splenectomy.
UT MD Anderson Cancer Center
Syed Yusuf is a Cardiologist in Houston, Texas. Dr. Yusuf is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Cardiomyopathy, Large-Cell Immunoblastic Lymphoma, Alveolar Soft Part Sarcoma, and Adult Soft Tissue Sarcoma.
Office
Partow Kebriaei is a Hematologist in Houston, Texas. Dr. Kebriaei is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.
Dr. Sravanti Teegavarapu specializes in benign and malignant hematological diseases. She is an Assistant Professor of Medicine - Hematology and Oncology and Medical Director of Hematology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Teegavarapu’s clinical interests include lymphomas and other blood diseases. Dr. Teegavarapu received her medical degree from the Armed Forces Medical College in Pune, India.She completed her residency at University of North Dakota in Fargo and postdoctoral fellowship at the M.D. Anderson Cancer Center in Houston. She also completed a fellowship at Houston Methodist Hospital/Weill Cornell Medical College.Dr. Teegavarapu is board-certified by the American Board of Internal Medicine, American Board of Hematology and the American Board of Oncology. In addition to English, Dr. Teegavarapu speaks Telugu and Hindi. Dr. Teegavarapu is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Diffuse Large B-Cell Lymphoma (DLBCL), and Large-Cell Immunoblastic Lymphoma.
Last Updated: 02/22/2026





